FWDDX | VEMIX | FWDDX / VEMIX | |
Total Expense Ratio | 0.89 | 0.09 | 989% |
Annual Report Gross Expense Ratio | 0.89 | 0.09 | 989% |
Fund Existence | 5 years | 25 years | - |
Gain YTD | 23.330 | 17.423 | 134% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.03B | 130B | 2% |
Annual Yield % from dividends | 1.36 | 2.68 | 51% |
Returns for 1 year | 23.41 | 19.67 | 119% |
Returns for 3 years | 49.13 | 37.62 | 131% |
Returns for 5 years | N/A | 29.47 | - |
Returns for 10 years | N/A | 81.86 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MSEGX | 64.30 | 0.80 | +1.26% |
Morgan Stanley Inst Growth A | |||
PHLAX | 34.06 | 0.26 | +0.77% |
PGIM Jennison Health Sciences A | |||
GMVIX | 17.01 | 0.08 | +0.47% |
Goldman Sachs Small/Mid Cap Equity Inv | |||
CECYX | 29.47 | N/A | N/A |
Columbia Large Cap Enhanced Core Inst3 | |||
KGROX | 13.34 | N/A | N/A |
Kennedy Capital Small Cap Growth Instl |